Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study.
作者信息
Visentin Andrea, Mauro Francesca Romana, Cibien Francesca, Vitale Candida, Reda Gianluigi, Fresa Alberto, Ciolli Stefania, Pietrasanta Daniela, Marchetti Monia, Murru Roberta, Gentile Massimo, Rigolin Gian Matteo, Quaglia Francesca Maria, Scarfò Lydia, Sportoletti Paolo, Pravato Stefano, Piazza Francesco, Coscia Marta, Laurenti Luca, Molica Stefano, Foà Robin, Cuneo Antonio, Trentin Livio
机构信息
Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padova, Italy.
Venetian Institute of Molecular Medicine, Padua, Italy.
出版信息
Am J Hematol. 2022 Mar 1;97(3):E95-E99. doi: 10.1002/ajh.26437. Epub 2021 Dec 21.
PMID:34904743
Abstract
摘要
Zotero 插件